SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001011443-02-000011
Filing Date
2002-02-14
Accepted
2002-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 LYNX THERAPEUTICS SCHEDULE 13G/A-1 lynx13g-a1.txt SC 13G/A 3341
  Complete submission text file 0001011443-02-000011.txt   5284
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45862 | Film No.: 02545396
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 300 CRESCENT CT STE 700 DALLAS TX 75201
Business Address 300 CRESCENT CT STE 700 DALLAS TX 75201 8178706100
HBK INVESTMENTS L P (Filed by) CIK: 0001011443 (see all company filings)

IRS No.: 752622581 | State of Incorp.: DE | Fiscal Year End: 1231